Capital Fund Management (CFM)
SAGE icon

Capital Fund Management (CFM)’s Sage Therapeutics SAGE Stock Holding History

Capital Fund Management (CFM)’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-39,700
Closed -$744K – 2132
2024
Q1 		$744K Sell
39,700
-16,700
-30% -$385K ﹤0.01% 1791
2023
Q4 		$1.22M Buy
56,400
+45,600
+422% +$904K ﹤0.01% 1760
2023
Q3 		$222K Buy
+10,800
New +$312K ﹤0.01% 1896

Other funds holding SAGE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RTW Investments
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Bellevue Group
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Capital Fund Management (CFM)'s SAGE Position: Q3 2024 in Review

Capital Fund Management (CFM) sold out of Sage Therapeutics (SAGE) in Q3 2024, closing a stake of 196,543 shares — an estimated $2.13M sold.

Capital Fund Management (CFM) first reported a position in SAGE in Q4 2017 and held it in 18 quarters. The position peaked at $4.74M in Q1 2021. 176 funds tracked by Wall St. Rank hold SAGE as of Q3 2024.

  • Capital Fund Management (CFM) reported no remaining Sage Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 196,543 Sage Therapeutics shares in Q3 2024, an estimated $2.13M.
  • Capital Fund Management (CFM) first reported a position in Sage Therapeutics in Q4 2017 and held it in 18 quarters.
  • Capital Fund Management (CFM)'s Sage Therapeutics position peaked at $4.74M in Q1 2021.
  • 176 funds tracked by Wall St. Rank held Sage Therapeutics as of Q3 2024.

Based on Capital Fund Management (CFM)'s 13F filing for Q3 2024, filed 13 Nov 2024.